A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms
Clinical trial NCT03603951 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03603951
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-14
- Primary completion
- 2026-02-14
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.